title: Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists.
abstract: OBJECTIVE
  In this retrospective study, we compared the effects of histamine H2-receptor antagonists to those of antacids and anticholinergics in patients with hemorrhagic ulcers with various endoscopic appearances of bleeding.
  
  
  METHODS
  Patients with hemorrhagic ulcers (n = 376) were examined by emergency endoscopy and were treated with 1) antacids and anticholinergic drugs or 2) H2-receptor antagonists.
  
  
  RESULTS
  In ulcer patients with oozing or fresh red coagulation, H2-receptor antagonists ceased further hemorrhage more effectively (65.9% of the cases) than antacids and anticholinergic drugs (46.7%). In patients with projectile bleeding, both of the treatments failed to stop hemorrhage. There were no significant differences in favorable outcome in the patients only with old black coagulation between antacid and anticholinergic drugs-treated group and H2-receptor antagonists-treated group (94.4% and 93.8%, respectively).
  
  
  CONCLUSIONS
  The results suggest that H2-receptor antagonists are more effective than antacids and anticholinergic drugs in patents with peptic ulcer with fresh coagulation or oozing, but not with projectile bleeding or old black coagulation. The results also indicate that endoscopic appearances of peptic ulcer bleeding are good predictors for the effects of medication.
authors.affiliation: First Department of Medicine, Osaka University School of Medicine, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Fusamoto
authors.forename: S
authors.initials: S
authors.lastname: Kawano
authors.forename: S
authors.initials: S
authors.lastname: Tsuji
authors.forename: M
authors.initials: M
authors.lastname: Oshita
authors.forename: K
authors.initials: K
authors.lastname: Nagano
authors.forename: A
authors.initials: A
authors.lastname: Ohmae
authors.forename: H
authors.initials: H
authors.lastname: Sawaoka
authors.forename: Y
authors.initials: Y
authors.lastname: Nagai
authors.forename: A
authors.initials: A
authors.lastname: Kasahara
authors.forename: T
authors.initials: T
authors.lastname: Sugimoto
authors.forename: T
authors.initials: T
authors.lastname: Kamada
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D002927:Cimetidine / Q000627:therapeutic use; D016099:Endoscopy, Gastrointestinal; D015738:Famotidine / Q000627:therapeutic use; D005260:Female; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008276:Magnesium Hydroxide / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010438:Peptic Ulcer Hemorrhage / Q000188:drug therapy* / Q000473:pathology*; D011899:Ranitidine / Q000627:therapeutic use; D012189:Retrospective Studies; D012601:Scopolamine / Q000627:therapeutic use
chemical_list: D000863:Antacids; D018680:Cholinergic Antagonists; D006635:Histamine H2 Antagonists; D000536:Aluminum Hydroxide; D015738:Famotidine; D002927:Cimetidine; D011899:Ranitidine; D012601:Scopolamine; D008276:Magnesium Hydroxide